Understanding host immunity and the gut microbiota inspires the new development of vaccines and adjuvants

Kyosuke Yakabe, Jun Uchiyama, Masahiro Akiyama, Yun Gi Kim

研究成果: Review article査読

3 被引用数 (Scopus)

抄録

Vaccinations improve the mortality and morbidity rates associated with several infections through the generation of antigen-specific immune responses. Adjuvants are often used together with vaccines to improve immunogenicity. However, the immune responses induced by most on-going vaccines and adjuvants approved for human use vary in individuals; this is a limitation that must be overcome to improve vaccine efficacy. Several reports have indicated that the symbiotic bacteria, particularly the gut microbiota, impact vaccine-mediated antigen-specific immune responses and promote the induction of nonspecific responses via the “training” of innate immune cells. Therefore, the interaction between gut microbiota and innate immune cells should be considered to ensure the optimal immunogenicity of vaccines and adjuvants. In this review, we first introduce the current knowledge on the immunological mechanisms of vaccines and adjuvants. Subsequently, we discuss how the gut microbiota influences immunity and highlight the relationship between gut microbes and trained innate immunity, vaccines, and adjuvants. Understanding these complex interactions will provide insights into novel vaccine approaches centered on the gut microbiota.

本文言語English
論文番号163
ページ(範囲)1-22
ページ数22
ジャーナルPharmaceutics
13
2
DOI
出版ステータスPublished - 2021 1

ASJC Scopus subject areas

  • 薬科学

フィンガープリント

「Understanding host immunity and the gut microbiota inspires the new development of vaccines and adjuvants」の研究トピックを掘り下げます。これらがまとまってユニークなフィンガープリントを構成します。

引用スタイル